Weight loss injectables like Ozempic have gained popularity in Bengaluru, with patients sourcing them from abroad. The ...
In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ...
We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...
Eli Lilly (LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday. The ...
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...
"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Giftify (GIFT) announced a significant increase in gift card sales following its announcement of a smart savings program for GLP-1 diabetes and ...
Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. [ Sign up for ...